Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Sep 11, 2026
Canadian National Railway (CNI) Eases -4% After Hitting Recent Highs

Canadian National Railway (CNI) Eases -4% After Hitting Recent Highs

Key Takeaways

  • Canadian National Railway (CNR) shares pulled back roughly 4% over the trailing 30 days, easing from a 52-week high near $131.55 on the U.S.-listed shares.
  • Second-quarter 2026 results beat expectations, with revenue up 11% year over year to C$4.75 billion and adjusted EPS of C$2.08.
  • Management raised its full-year 2026 outlook to mid-to-high single-digit adjusted EPS growth on low single-digit volume (RTM) growth.
  • Record grain and potash volumes, alongside strength in petroleum and chemicals and automotive, drove the quarter's top-line expansion.
  • Fuel costs rose sharply, pressuring the adjusted operating ratio to 62.2% and partially offsetting productivity gains.

Current Market Snapshot

Canadian National Railway stands as one of North America's largest Class I railroads and serves as a bellwether for cross-border trade health. Over the trailing 30 days, the U.S.-listed shares (CNI) declined from a close near $126.32 to roughly $121.16, a move of about 4%. The stock reached a 52-week high near $131.55 in late July following a strong second-quarter earnings report, then moderated through August and into September. As of early September, the shares traded modestly below their 50-day moving average near $122.55 but remained well above the 200-day moving average near $112.74, reflecting a longer-term uptrend within a shorter-term consolidation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Canadian National Railway Business Overview and Competitive Position

Canadian National Railway operates a nearly 20,000-mile rail network that connects Canada's Atlantic and Pacific coasts with the U.S. Midwest and the U.S. Gulf Coast, giving it a unique three-coast reach. The company transports more than 300 million tons of freight annually across a diversified commodity mix that includes grain and fertilizers, petroleum and chemicals, automotive, intermodal, forest products, metals and minerals, and coal. This diversification, combined with extensive network connectivity and disciplined scheduled railroading operations, provides a competitive moat and makes CNR a closely watched indicator of North American industrial and agricultural activity.

Recent Developments Driving CNR

The most significant recent catalyst was the company's second-quarter 2026 earnings report released on July 24. CNR posted net income of C$1.25 billion, up from C$1.17 billion a year earlier, while revenue rose 11% to C$4.75 billion. Adjusted diluted EPS reached C$2.08, and the company beat consensus estimates. Record Canadian grain and potash volumes, an 18% increase in automotive revenue, and strong petroleum and chemicals demand underpinned the results. Freight revenue per carload rose 11.9% year over year, reflecting a favorable volume mix and yield.

Management responded by raising its 2026 guidance, now expecting low single-digit revenue ton-mile growth and mid-to-high single-digit adjusted diluted EPS growth. Productivity initiatives, including the "Fast Track" efficiency program, delivered close to C$100 million in realized benefits during the first half. However, fuel expense surged 59.6% year over year, adding roughly 210 basis points of pressure to the adjusted operating ratio, which widened to 62.2%.

Analyst activity has been broadly constructive but not uniformly bullish. Barclays lifted its price target to $130, Bank of America raised its target to $134 with a buy rating, and Evercore upgraded the stock to outperform, while others, including Benchmark and Susquehanna, maintained more cautious ratings. The consensus rating sits at "Hold" with an average price target near $137.40. CNR also continued returning capital to shareholders through share repurchases and a quarterly dividend of C$0.915 per share.

2026 Outlook and What Investors Should Watch

Looking ahead, several factors will shape CNR's performance through the remainder of 2026. Management expects Canadian grain strength to persist into the third quarter, supported by higher carry-outs from the record 2025-2026 crop, while petroleum and chemicals should benefit from refined-product growth and new crude oil business. Conversely, international intermodal faces headwinds from challenging North American import trends, and forest products and metals and minerals remain sensitive to housing starts, tariffs, and iron ore fundamentals.

Key macro variables include fuel prices, with management assuming West Texas Intermediate crude between $80 and $110 per barrel, and foreign exchange, with an updated Canadian-dollar assumption near $0.71 per U.S. dollar. Investors will also monitor CNR's C$2.8 billion capital program, its progress on the Fast Track productivity initiatives, the integration of recently announced memorandums of understanding with UNP, and any developments around broader North American rail consolidation, which has generated advisory costs and industry speculation involving NSC. Labor negotiations, regulatory changes, and the pace of share buybacks round out the key items to watch. From what I see, monitoring these elements closely will be important for positioning.

Exploring AI-Driven Trading Perspectives

I recently reviewed Tickeron's Trending AI Robots page to gain additional perspective on how algorithmic models are interpreting current price action and momentum in names like CNI. It highlights a curated selection of AI-driven trading bots that have demonstrated notable performance across a broad universe of stocks, allowing investors to explore automated approaches suited to different market conditions and risk preferences.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNR

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the designing, engineering, manufacturing and marketing external building products

Industry

Industry
N/A
Address
5020 Weston Parkway
Phone
+1 866 419-0042
Employees
21700
Web
https://www.cornerstonebuildingbrands.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).